Marvel Biosciences Corp: MDA EN

SEDARNov 28 18:10 ET · Announcements

Marvel Biosciences Corp: AUDITED ANNUAL FINANCIAL STATEMENTS EN

SEDARNov 28 17:17 ET · Announcements

Marvel Biosciences Announces Promising New Data From Rett Syndrome Study and Plans to Discuss Orphan and Rare Disease Status With the FDA

newsfileNov 26 07:00 ET

Marvel Biosciences Secures $300,000 Grant to Advance Groundbreaking Alzheimer's Research

newsfileNov 21 07:00 ET

Marvel Biosciences Corp. to Present at the Life Sciences Investor Forum November 14th

GlobeNewswireNov 13 08:35 ET

Marvel Biosciences Shares Positive Results of MB204 in the Oprm1 Model of Autism

newsfileOct 10 09:00 ET